1. Medtech Insight

Jury Awards $450m In Class-Action Charging Fraud In Gown Infection-Protection Claims

 
• By Elizabeth Orr

Halyard Health plans to appeal the verdict, which stems from allegations the company and its former parent, Kimberly-Clark, fraudulently promoted surgical gowns as offering more protection than they really did.

Kimberly-Clark Corp. and its spinoff Halyard Health Inc. plan to appeal after a California federal jury awarded more than $450m in a class-action suit involving MicroCool surgical gowns.

The plaintiff, Bahamas Surgery Center, filed suit on behalf of 500,000 health workers in 2014 alleging that Kimberly-Clark Corp., which spun off Halyard that same year as a standalone health-products company to market the gowns and other devices, falsely claimed that its MicroCool and other surgical gowns offered protection against the Ebola virus. California allowed the case to proceed as a class-action suit last November

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

Beyond The Bladder: Incontinence Impacts Mental Health

 
• By Brian Bossetta

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

AI Rollout Aims To Accelerate FDA’s Product Review Process

 
• By Elizabeth Orr

The FDA plans to implement artificial intelligence in its scientific review process by 30 June, following a successful pilot. The agency hopes the tool will reduce nonproductive tasks for reviewers amid recent staff cuts. A Chief AI Officer will oversee the rollout and integration.

Access To Library Tools Being Restored At US FDA

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals and laid off librarians have not been reinstated.